CervoMed (CRVO) Stock Forecast & Price Target

$1.99 +0.05 (+2.58%)

(As of 11:03 AM ET)

CervoMed - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 9 Analyst Ratings

Sell
1

Hold
4

Buy
4

Based on 9 Wall Street analysts who have issued ratings for CervoMed in the last 12 months, the stock has a consensus rating of "Hold." Out of the 9 analysts, 1 has given a sell rating, 4 have given a hold rating, 3 have given a buy rating, and 1 has given a strong buy rating for CRVO.

Consensus Price Target

$42.00
2,010.55% Upside

According to the 9 analysts' twelve-month price targets for CervoMed, the average price target is $42.00. The highest price target for CRVO is $63.00, while the lowest price target for CRVO is $12.00. The average price target represents a forecasted upside of 2,010.55% from the current price of $1.99.

Get the Latest News and Ratings for CRVO and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CervoMed and its competitors.

CRVO Analyst Ratings Over Time

Type	Current Forecast 12/19/23 to 12/18/24	1 Month Ago 11/19/23 to 11/18/24	3 Months Ago 9/20/23 to 9/19/24	1 Year Ago 12/19/22 to 12/19/23
Strong Buy	1 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	N/A
Buy	3 Buy rating(s)	5 Buy rating(s)	5 Buy rating(s)	N/A
Hold	4 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	$42.00	$53.60	$53.60	N/A
Forecasted Upside	2,010.55% Upside	414.89% Upside	206.81% Upside	N/A
Consensus Rating	Hold	Buy	Buy	N/A

A conspiracy Trump won’t unseal (Ad)

New documentary reveals the lost wealth-building secret hidden deep within ancient religious texts from almost every civilization… an investment one expert says is “so perfect that only God could have created it.” Watch it now to discover how this asset that you’ve likely never considered before can produce returns so safe, secure, and endless it is nothing short of miraculous.

This is the untold, true story of God’s Investment.

CRVO Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CRVO Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CervoMed Stock vs. The Competition

Type	CervoMed	Medical Companies	S&P 500
Consensus Rating Score	2.44	2.81	2.51
Consensus Rating	Hold	Moderate Buy	Moderate Buy
Predicted Upside	2,064.95% Upside	28,497.71% Upside	12.06% Upside
News Sentiment Rating	Neutral News See Recent CRVO News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/17/2024	HC Wainwright 2 of 5 stars	R. Selvaraju Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral
12/11/2024	Canaccord Genuity Group 1 of 5 stars		Lower Target	Buy ➝ Buy	$65.00 ➝ $12.00	+488.23%
12/11/2024	Morgan Stanley 3 of 5 stars		Reiterated Rating	Overweight ➝ Underweight
12/11/2024	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	D. Gataulin Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Neutral
12/10/2024	Brookline Capital Management Subscribe to MarketBeat All Access for the recommendation accuracy rating	T. Bussian Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
12/10/2024	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
12/6/2024	Roth Mkm Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$45.00	+362.96%
12/5/2024	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	B. Pachaiyappan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 11:21 AM ET.

CRVO Forecast - Frequently Asked Questions

: According to the research reports of 9 Wall Street equities research analysts, the average twelve-month stock price forecast for CervoMed is $42.00, with a high forecast of $63.00 and a low forecast of $12.00.
: 9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CervoMed in the last twelve months. There is currently 1 sell rating, 4 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" CRVO shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRVO, but not buy additional shares or sell existing shares.
: According to analysts, CervoMed's stock has a predicted upside of 2,010.55% based on their 12-month stock forecasts.
: Over the previous 90 days, CervoMed's stock had 2 downgrades and 1 upgrade by analysts.
: CervoMed has been rated by research analysts at Brookline Capital Management, Canaccord Genuity Group, Chardan Capital, D. Boral Capital, HC Wainwright, Morgan Stanley, Roth Capital, and Roth Mkm in the past 90 days.
: Analysts like CervoMed less than other "medical" companies. The consensus rating for CervoMed is Hold while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CRVO compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Forbes rich list released… #1 to be assassinated? (Ad)

Elon Musk has just exposed the “energy grift” of America in a recent tweet to his platform, X. And people are slowly starting to wake up to the Deep State’s lies.

To get the full details on the fake “energy crisis” of America, watch this now

This page (NASDAQ:CRVO) was last updated on 12/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CervoMed (CRVO) Stock Forecast & Price Target